ICMR will choose 20 healthcare facilities, largely government-run hospitals, across India to begin clinical trials for convalescent plasma transfusion therapy, a treatment that is being explored for critically-ill Covid-19 patients.from Industry-Economic Times
Read The Rest:economictimes...
